Target intelligence / Profile preview

macrophage stimulating 1 pseudogene 2 (MST1P2)

Target
MST1P2
Molecular classification
Other (Pseudogene)
01

Overview

macrophage stimulating 1 pseudogene 2 (MST1P2) is classified as a pseudogene, meaning it is an inactive segment of DNA that is similar to a functional gene but does not encode a functional protein. It is related to the functional macrophage stimulating 1 (MST1) gene, which codes for the cytokine MSP, but MST1P2 does not encode a protein product and has no known biological or disease function as a protein, receptor, or therapeutic target[1][4][7][8][14]. MST1P2 is not an active protein or receptor, but a pseudogene, meaning the information does not pertain to a therapeutic target. The related active protein is MSP, encoded by MST1, which is a cytokine involved in macrophage signaling[6][12]. There are no drugs, mechanisms of action, or known biomarker or safety issues associated with the pseudogene MST1P2[4][14]. Claims found in some databases that MST1P2 might play a regulatory RNA role (as in cancer progression via sponging microRNA) are not equivalent to it being a classic protein therapeutic target or receptor[8]. If you are seeking information about the functional target in the macrophage stimulating protein pathway, you should look for macrophage stimulating 1 (MST1) or macrophage stimulating 1 receptor (MST1R, also known as RON), not MST1P2[11][12][13]. Summary statement: MST1P2 is a pseudogene, not a receptor or enzyme, with no established role as a therapeutic target[4][7][14]. Any apparent confusion with the actual targetable protein (MSP, MST1) should be clarified for downstream structured data collection.

Other names
MSPL-2MSPL2MSTP2

Beyond the preview

Go deeper on macrophage stimulating 1 pseudogene 2 (MST1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on macrophage stimulating 1 pseudogene 2 (MST1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call